Proto Labs, Inc. (NYSE: PRLB) reported first‑quarter 2026 results on May 1, 2026, delivering record revenue of $139.3 million, a 10.4% year‑over‑year increase, and a non‑GAAP earnings per share of $0.54, up 63.6% from $0.33 in Q1 2025. The earnings beat analyst estimates of $0.40 by $0.14, a 35% overrun, while revenue surpassed the consensus of $132.7 million.
Gross profit rose to $63.6 million, and the non‑GAAP gross margin expanded to 46.2% from 44.8% in the prior year, reflecting a higher mix of high‑margin services and disciplined cost control. The GAAP gross margin of 45.6% also improved from 44.1% in Q1 2025.
Segment performance was led by CNC machining, which generated $63.2 million in revenue, up 17.6% year‑over‑year, and accounted for 45% of total sales. Injection molding and 3D printing contributed $30.5 million and $25.1 million respectively, with 3D printing remaining flat compared with the prior year. Proto Labs also highlighted its ISO 13485 certifications for metal 3D printing and injection molding, positioning the company to capture growth in regulated medical device markets.
Management reiterated its 2026 guidance, maintaining a revenue growth outlook of 6%–8% for Q2 2026 and a non‑GAAP EPS range of $0.50 to $0.58. The guidance is consistent with the Q1 results and signals confidence in sustained demand and margin expansion. CEO Suresh Krishna said, “Protolabs started 2026 very strong, delivering another record revenue quarter. We achieved double‑digit revenue growth, gross margin expansion, and operating expense leverage. These results reflect strong demand for Protolabs' digital manufacturing services, and disciplined execution across the business.”
Proto Labs continues to invest in its AI‑enabled ProDesk platform and expand its medical device production capabilities. The company’s focus on improving the customer experience, accelerating innovation, expanding production, and driving operational efficiency is expected to deepen relationships with larger, production‑oriented customers, as evidenced by a 20.4% increase in revenue per customer contact. However, the company faces headwinds in the European market, where organic revenue remains weak, and capacity constraints in CNC machining and 3D printing could limit growth.
Investors reacted positively to the results, citing the strong EPS beat, robust guidance, and margin expansion as key drivers of confidence in Proto Labs’ continued double‑digit growth trajectory.
With a strong balance sheet, zero debt, and $158 million in cash and investments, Proto Labs is well positioned to capitalize on the expanding digital manufacturing market and to further scale its hybrid fulfillment model.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.